Esophageal Atresia

condition

Last mentioned: Mar 20, 2026

Timeline

  1. Regulatory Review

    Target window for potential FDA/EMA orphan drug or breakthrough device designation filing.

  2. Expanded Trials

    Anticipated commencement of multi-center trials for broader pediatric applications.

  3. Phase I Clinical Data

    Expected release of initial safety data from first-in-human pilot studies.

  4. Breakthrough Announced

    First successful development of a lab-grown oesophagus for pediatric use is reported.

Stories mentioning Esophageal Atresia 1

clinical-trial Very Bullish

First Lab-Grown Oesophagus Breakthrough Offers Hope for Rare Pediatric Conditions

A groundbreaking medical milestone has been achieved with the development of the first lab-grown oesophagus, offering a transformative treatment for children born with rare congenital conditions. This regenerative medicine breakthrough uses tissue engineering to create functional organs, potentially replacing invasive surgeries that currently rely on repositioning other digestive organs.

3 sources